Cite
APA Citation
Fowler, N. H., Nastoupil, L., De Vos, S., Knapp, M., Flinn, I. W., Chen, R., Advani, R. H., Bhatia, S., Martin, P., Mena, R., Davis, R. E., Neelapu, S. S., Eckert, K., Ping, J., Co, M., Beaupre, D. M., Neuenburg, J. K., & Palomba, M. L. (2020). the combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphoma. British journal of haematology, 189, 650–660. http://access.bl.uk/ark:/81055/vdc_100103771019.0x000030